营养表观遗传学:生物活性饮食化合物在骨关节炎的表观遗传调节中的作用
Karla Mariuxi Villagrán-Andrade1, Carmen Núñez-Carro1, Francisco J Blanco1,2
1Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
概括
来自植物的生物活性化合物,作为天然表观遗传调节剂,通过影响基因表达和表观遗传变化来保护骨关节炎. 需要进一步的研究来探索它们的临床潜力,以实现个性化的营养和疾病预防.
科学领域:
- 营养表观基因组学
- 植物衍生生物活性化合物植物衍生生物活性化合物
- 骨关节炎的发病原因
背景情况:
- 营养表观基因组学探讨了食物化合物与表观基因组的相互作用.
- 植物营养素调节表观遗传机制,如DNA甲基化和基因素修饰.
- 这些化合物抑制了与骨关节炎有关的炎症和代谢介质.
研究的目的:
- 审查植物衍生生物活性化合物对骨关节炎的冠状腺保护性质.
- 评估它们作为自然表观遗传调节剂的潜力.
- 突出其在骨关节炎的管理,治疗和预防中的作用.
主要方法:
- 关于人类和动物研究的综合文献综述.
- 对作为表观遗传调节剂的生物活性化合物研究的分析.
- 检查冠状动脉保护作用和机制.
主要成果:
- 生物活性化合物显示出对骨关节炎的冠状动脉保护作用.
- 它们调节炎症基因和非编码RNA中的表观遗传变化.
- 自然表观遗传调节剂的组合提供了协同效益,副作用较少.
结论:
- 植物衍生生物活性化合物对骨关节炎管理具有治疗潜力.
- 进一步的研究对于验证它们的临床应用和个性化营养策略至关重要.
- 了解它们与基因组和营养环境的相互作用是未来预防的关键.
相关概念视频
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K


